Generation Bio Co Strategic Asset Allocation Index
Generation Bio Co strategic asset allocation index. Generation Bio Co (GBIO) has a Strategic Asset Allocation Index of 14.4% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $15.04 Million) total $15.04 Million, measured against net assets of $104.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Generation Bio Co's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Generation Bio Co (2020–2022)
Strategic asset allocation index of Generation Bio Co from 2020 to 2022. This chart shows how Generation Bio Co's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2024, the index stands at 14.4%, representing strategic assets of $15.04 Million against net assets of $104.44 Million USD. Check GBIO goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Generation Bio Co Strategic Asset Allocation Index by Year (2020–2022)
Generation Bio Co strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Generation Bio Co from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Generation Bio Co.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 7.9% | $22.21 Million | $22.21 Million | $- | $282.49 Million | ▲ +1.1 pp |
| 2021 | 6.8% | $25.89 Million | $25.89 Million | $- | $381.75 Million | ▼ -2.1 pp |
| 2020 | 8.9% | $23.78 Million | $23.78 Million | $- | $268.01 Million | — |